Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 11/20 | 0.71 |
| ▸ | ADORA1 | P30542 | 8/20 | 0.69 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | THPO | P40225 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL242987 | 0.88 | ADORA2B (0.62) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL1945210 | 0.85 | ADORA2B (0.86) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL1947341 | 0.83 | ADORA2B (0.69) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL1945203 | 0.83 | ADORA2B (1.00) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL1944932 | 0.81 | ADORA2B (1.00) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL2329441 | 0.79 | ADORA2B (1.00) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL242345 | 0.77 | ADORA2B (1.00) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL1947287 | 0.75 | ADORA2B (1.00) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL11066982 | 0.75 | SIRT1 (0.45) | ADORA2BADORA1ADORA2AADORA3KDM4E | |
| SCHEMBL1946410 | 0.75 | ADORA2B (0.86) | ADORA2BADORA1ADORA2AADORA3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1996201-A2 | METHOD OF PREVENTING AND TREATING HEPATIC DISEASE USING A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS, INC. (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007109547-A2 | METHOD OF PREVENTING AND TREATING HEPATIC DISEASE USING A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS, INC. (US) | 2007-09-27 | — | — | WO | disclosed |